COX-2-PGE 2 -EPs in gynecological cancers
ConclusionEPs represent promising anti-inflammation biomarkers for gynecological cancer and may be novel treatment targets in the near future.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Endometrial Cancer | OBGYN | Ovarian Cancer | Ovaries | Study